Diferencia entre revisiones de «Nonsteroidal anti-inflammatory drugs»
 
(No se muestran 6 ediciones intermedias de 4 usuarios)
Línea 5: Línea 5:


===Salicylates===
===Salicylates===
* [[Aspirin]] ([[acetylsalicylic acid]])
*[[Aspirin]] ([[acetylsalicylic acid]])
* [[Diflunisal]] (Dolobid)
*Salicylic acid and other [[salicylates]]
* [[Salicylic acid]] and other [[salicylate]]s
* [[Salsalate]] (Disalcid)


===Propionic acid derivatives===
===Propionic acid derivatives===
* [[Ibuprofen]]<ref name="urlDrugBank: Ibuprofen (DB01050)">{{cite web | url = http://www.drugbank.ca/cgi-bin/getCard.cgi?CARD=APRD00372 | title =Ibuprofen | format = | work = DB01050  | publisher = DrugBank }}</ref>
*[[Ibuprofen]]
* [[Dexibuprofen]]
*[[Naproxen]]
* [[Naproxen]]
*[[Ketoprofen]]
* [[Fenoprofen]]
* [[Ketoprofen]]
* [[Dexketoprofen]]
* [[Flurbiprofen]]
* [[Oxaprozin]]
* [[Loxoprofen]]


===Acetic acid derivatives===
===Acetic acid derivatives===
* [[Indomethacin]]
*[[Indomethacin]]
* [[Tolmetin]]
*[[Ketorolac]]
* [[Sulindac]]
*[[Diclofenac]]  
* [[Etodolac]]
* [[Ketorolac]]
* [[Diclofenac]] (Safety alert by FDA<ref>{{cite web|url=http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm193047.htm |title=Voltaren Gel (diclofenac sodium topical gel) 1% - Hepatic Effects Labeling Changes |publisher=Fda.gov |date=2009-12-04 |accessdate=2012-11-30}}</ref>)
* [[Aceclofenac]]
*[[Nabumetone]] (drug itself is non-acidic but the active, principal metabolite has a carboxylic acid group)


===Anthranilic acid derivatives (Fenamates)===
===Selective COX-2 inhibitors (Coxibs)===
* [[Mefenamic acid]]
*[[Celecoxib]] (FDA alert<ref>Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm</ref>)
* [[Meclofenamic acid]]
* [[Flufenamic acid]]
* [[Tolfenamic acid]]


===Selective COX-2 inhibitors (Coxibs)===
===Enolic acid (Oxicam) derivatives===
* [[Celecoxib]] (FDA alert<ref>Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm</ref>)
*Piroxicam
*[[Meloxicam]]
*Tenoxicam
*Droxicam


==See Also==
==See Also==
Línea 46: Línea 33:
*[[Toxicology (Main)]]
*[[Toxicology (Main)]]


==Sources==
==References==
<references/>
<references/>
[[Category:Pharmacology]]

Revisión actual - 15:21 22 ago 2017

Background

  • Abbreviation: NSAIDs

Types

Salicylates

Propionic acid derivatives

Acetic acid derivatives

Selective COX-2 inhibitors (Coxibs)

Enolic acid (Oxicam) derivatives

See Also

References

  1. ↑ Information for Healthcare Professionals: Celecoxib (marketed as Celebrex) http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm124655.htm
Obtenido de «https://www.wikem.org/w/index.php?title=Nonsteroidal_anti-inflammatory_drugs&oldid=152624»